Sofinnova Investments as of March 31, 2021
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 64 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera Comm (NTRA) | 18.9 | $315M | 3.1M | 101.54 | |
| Karuna Therapeutics Comm | 14.1 | $235M | 2.0M | 120.23 | |
| Bolt Biotherapeutics Comm | 5.4 | $91M | 2.8M | 32.91 | |
| Ascendis Pharma A/S Adr (ASND) | 4.0 | $67M | 522k | 128.88 | |
| Y-mAbs Therapeutics Comm | 4.0 | $66M | 2.2M | 30.24 | |
| AstraZeneca Adr (AZN) | 3.1 | $52M | 1.0M | 49.72 | |
| Health Care Select Sector SPDR Comm Put Option | 2.8 | $47M | 400k | 116.74 | |
| Checkmate Pharmaceuticals Comm | 2.6 | $44M | 3.6M | 12.14 | |
| Jazz Pharmaceuticals Comm (JAZZ) | 2.5 | $42M | 256k | 164.37 | |
| Inozyme Pharma Comm (INZY) | 2.4 | $40M | 2.0M | 19.80 | |
| United Therapeutics Corp Comm (UTHR) | 2.2 | $36M | 215k | 167.27 | |
| Eli Lilly and Comm (LLY) | 2.0 | $34M | 181k | 186.82 | |
| Nucana Biomed Adr | 1.7 | $28M | 5.6M | 4.99 | |
| Merus Comm (MRUS) | 1.6 | $27M | 1.3M | 20.89 | |
| Galera Therapeutics Comm (GRTX) | 1.6 | $27M | 3.1M | 8.82 | |
| Nextcure Comm (NXTC) | 1.6 | $27M | 2.7M | 10.01 | |
| Align Technology Comm (ALGN) | 1.5 | $25M | 46k | 541.54 | |
| Acceleron Pharma Comm | 1.5 | $24M | 179k | 135.61 | |
| Reata Pharmaceuticals Comm | 1.4 | $24M | 239k | 99.70 | |
| Mirati Therapeutics Comm | 1.4 | $24M | 138k | 171.30 | |
| Intra-Cellular Therapies Comm (ITCI) | 1.3 | $22M | 655k | 33.93 | |
| PTC Therapeutics Comm (PTCT) | 1.3 | $22M | 467k | 47.35 | |
| Insmed Comm (INSM) | 1.3 | $21M | 619k | 34.06 | |
| Akouos Comm | 1.3 | $21M | 1.5M | 13.87 | |
| Gilead Sciences Comm Call Option | 1.2 | $19M | 300k | 64.63 | |
| Exelixis Comm (EXEL) | 1.1 | $19M | 839k | 22.59 | |
| Protagonist Therapeutics Comm (PTGX) | 1.0 | $17M | 655k | 25.90 | |
| ObsEva SA Comm | 0.9 | $15M | 4.7M | 3.25 | |
| Uniqure NV Comm (QURE) | 0.9 | $14M | 427k | 33.69 | |
| Regenxbio Comm (RGNX) | 0.7 | $12M | 362k | 34.11 | |
| Horizon Therapeutics Comm | 0.7 | $12M | 134k | 92.04 | |
| Nucana Biomed Ordinary Shares | 0.7 | $12M | 2.4M | 4.99 | |
| Vertex Pharmaceuticals Comm (VRTX) | 0.6 | $9.8M | 46k | 214.88 | |
| Dexcom Comm (DXCM) | 0.6 | $9.7M | 27k | 359.41 | |
| Amgen Comm (AMGN) | 0.6 | $9.7M | 39k | 248.82 | |
| Agenus Comm | 0.6 | $9.5M | 3.5M | 2.72 | |
| Mirum Pharmaceuticals Comm (MIRM) | 0.6 | $9.4M | 476k | 19.82 | |
| Athira Pharma Comm (ATHA) | 0.6 | $9.4M | 509k | 18.40 | |
| ChemoCentryx Comm | 0.6 | $9.2M | 180k | 51.24 | |
| Cytokinetics Comm (CYTK) | 0.5 | $9.1M | 390k | 23.26 | |
| ChemoCentryx Comm Put Option | 0.5 | $7.7M | 150k | 51.24 | |
| TCR2 Therapeutics Comm | 0.4 | $7.4M | 337k | 22.08 | |
| Amarin Corp Adr | 0.4 | $7.3M | 1.2M | 6.21 | |
| Syndax Pharmaceuticals Comm (SNDX) | 0.4 | $6.7M | 299k | 22.36 | |
| Coherus BioSciences Comm (CHRS) | 0.4 | $6.3M | 435k | 14.61 | |
| Arena Pharmaceuticals Comm | 0.4 | $6.3M | 91k | 69.39 | |
| Marinus Pharmaceuticals Comm | 0.3 | $5.7M | 370k | 15.48 | |
| Jounce Therapeutics Comm | 0.3 | $5.3M | 512k | 10.27 | |
| Insulet Corp Comm (PODD) | 0.3 | $4.6M | 18k | 260.91 | |
| Fate Therapeutics Comm (FATE) | 0.3 | $4.5M | 55k | 82.45 | |
| Replimune Group Comm (REPL) | 0.3 | $4.3M | 142k | 30.51 | |
| Immatics NV Comm (IMTX) | 0.3 | $4.3M | 385k | 11.21 | |
| Aligos Therapeutics Comm | 0.3 | $4.2M | 186k | 22.74 | |
| Aptose Biosciences Comm | 0.3 | $4.2M | 697k | 5.97 | |
| Heron Therapeutics Comm Call Option | 0.2 | $4.1M | 250k | 16.21 | |
| BioCryst Pharmaceuticals Comm (BCRX) | 0.2 | $3.9M | 379k | 10.17 | |
| Savara Comm (SVRA) | 0.2 | $3.6M | 1.7M | 2.08 | |
| Puma Biotechnology Comm (PBYI) | 0.2 | $3.4M | 345k | 9.72 | |
| Otonomy Comm | 0.2 | $3.2M | 1.3M | 2.55 | |
| Kura Oncology Comm (KURA) | 0.1 | $2.4M | 83k | 28.27 | |
| MacroGenics Comm (MGNX) | 0.1 | $2.3M | 73k | 31.84 | |
| Synlogic Comm | 0.1 | $2.1M | 575k | 3.58 | |
| Calithera Biosciences Comm | 0.1 | $1.8M | 758k | 2.42 | |
| PDS Biotechnology Corporation Comm (PDSB) | 0.0 | $649k | 143k | 4.55 |